Screening for High-risk Chronic Obstructive Pulmonary Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: questionnaire survey.
- Who it may be relevant to
- Registry conditions: High-risk COPD. Basic parameters: 18 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Screening Study at High-risk Chronic Obstructive Pulmonary Disease
Overview
This study is a multicenter cross-sectional study design aimed at screening risk factors for the combination of disease and syndrome in high-risk individuals with chronic obstructive pulmonary disease (COPD).
Detailed description
Targeting high-risk populations for chronic obstructive pulmonary disease (COPD), targeted at key issues such as unclear risk factors and lack of prevention and treatment plans, high-risk population screening was conducted to identify risk factors. This study is expected to detect at least 3600 high-risk individuals with early-stage chronic obstructive pulmonary disease. The incidence rate of high-risk individuals in the early stage of chronic obstructive pulmonary disease is 30%, which means the total screening population is 12000 cases.
Interventions
- Other questionnaire survey
subjects fill out questionnaires
Primary outcome measures
- COPD screening questionnaire from Terrassa (EGARPOC) [Time frame: During screening]
- COPD assessment in primary care to identify undiagnosed respiratory disease and exacerbation risk questionnaire (CAPTURE) [Time frame: During screening]
- COPD Assessment Test (CAT) [Time frame: During screening]
- COPD screening questionnaire (COPD-Q) [Time frame: During screening]
- chronic obstructive pulmonary disease diagnostic questionnaire (CDQ) [Time frame: During screening]
- modified chronic obstructive pulmonary disease diagnostic questionnaire (mCDQ) [Time frame: During screening]
- Simple screening questionnaire [Time frame: During screening]
- lung function questionnaire (LFQ) [Time frame: During screening]
- chronic obstructive pulmonary disease screening questionnaire (COPD-SQ) [Time frame: During screening]
- chronic obstructive pulmonary disease population screener questionnaire (COPD-PS) [Time frame: During screening]
Eligibility criteria
Inclusion criteria
- According to the Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease (Revised in 2021), a multi-stage cluster random sampling method was used to select individuals from representative administrative villages with a history of chronic cough or sputum production, breathing difficulties, recurrent lower respiratory tract infections, and/or exposure to potential risk factors for chronic obstructive pulmonary disease.
- The investigators agreed to participate in this clinical study by voluntarily signing an informed consent form.
Exclusion criteria
- Patients who are delirious, have impaired consciousness, dementia, various psychiatric disorders, etc., and cannot be accurately informed of their basic physical condition.
- Patients who, in the opinion of the investigator, are not suitable for participation in this study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Other
Study locations
China · 1 center
- The First Affiliated Hospital of Henan University of Chinese Medicine — Zhengzhou
Identifiers
NCT: NCT06350305 · Screening for high-risk COPD